Dublin, April 20, 2026 (GLOBE NEWSWIRE)-- The "Organs-on-Chips Market: Industry Trends and Global Forecasts, Till 2035" report has been added to ResearchAndMarkets.com's offering. The global ...

In April 2025, the U.S. Food and Drug Administration (FDA) released a strategic roadmap to make animal testing the exception for preclinical safety and toxicity studies within the next three to five ...

A Nature Biomedical Engineering review synthesises how organoids and organ-on-a-chip technologies are transforming the ...

The US Food and Drug Administration has taken active steps to reduce dependence on animal-based studies to test new drugs and biomedical products.

Rhabdomyolysis is a condition in which muscle damage—often caused by drug intake—can lead to impaired kidney function and acute kidney failure. However, there have been limitations in directly ...

Chicago, Feb. 09, 2026 (GLOBE NEWSWIRE) -- The global organ on a chip market was valued at 157.06 million in 2024 and is expected to reach US$ 2,238.28 million by 2033, growing at a CAGR of 34.34% ...

CN Bio, a leading Organ-on-a-chip (OOC) company de-risking drug discovery and development pipelines by enabling earlier, more ...

Models of human disease are beneficial for medical research, but have limitations in predicting the way a drug will behave within the human body using data from non-human models because of inherent ...

A regulatory shift is underway in biomedical research and drug development. New Approach Methodologies are gaining momentum as human-relevant alternatives to animal testing. This transition is driving ...

New organ-on-a-chip platform allows the testing of cancer vaccine efficacy in aging populations, which may help guide the development of next-generation immunotherapies designed to meet the needs of ...

Dr. Vadim Jucaud's lab at the Terasaki Institute has introduced a new organ-on-a-chip platform that recapitulates age-dependent immune responses, offering a more accurate testing bed for evaluating ...